Ema Kantorova
Overview
Explore the profile of Ema Kantorova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Biringer K, Sivak S, Sivakova J, Ruzinak R, Martinikova M, Kantorova E, et al.
Neuro Endocrinol Lett
. 2021 Aug;
42(4):222-228.
PMID: 34436842
Objectives: Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease. This study evaluated pregnancy-related issues in patients with MS in one perinatological centre. Material And Methods: A single-centre, retrospective...
12.
Kantorova E, Hnilicova P, Bogner W, Grendar M, Grossmann J, Kovacova S, et al.
Neurol Res
. 2021 Jul;
44(1):57-64.
PMID: 34313578
Objectives: Multiple sclerosis (MS) is an inflammatory demyelinating disease that may cause physical disabling as well as cognitive dysfunction. The presented study investigated how the neuropsychological status depends on the...
13.
Koprusakova M, Grofik M, Kantorova E, Jungova P, Chandoga J, Kolisek M, et al.
BMC Neurol
. 2021 Jul;
21(1):293.
PMID: 34311727
Background: Charcot-Marie-Tooth 1C (CMT1C) is a rare form of dominantly inherited CMT1 neuropathy caused by a mutated gene encoding lipopolysaccharide-induced tumour necrosis alpha factor (LITAF). Case Presentation: We report a...
14.
Szilasiova J, Gazda J, Cimprichova A, Cvengrosova A, Donath V, Fedicova M, et al.
Neurol Res
. 2021 Jul;
44(1):38-46.
PMID: 34261427
Objective: : Neuromyelitis optica spectrum disorders (NMOSDs) are a group of rare, inflammatory, demyelinating diseases that affect the central nervous system. Neither the incidence nor the prevalence of NMOSD has...
15.
Kantorova E, Hnilicova P, Bogner W, Grendar M, cierny D, Heckova E, et al.
Mult Scler Relat Disord
. 2021 May;
52:102978.
PMID: 34015640
Background: The latest diagnostic criteria for multiple sclerosis (MS) have revitalized the role of oligoclonal bands synthesis in the cerebrospinal fluid (CSF-OCB). This study identifies predictors of CSF-OCB-positivity among in ...
16.
Ruzinak R, Bittsansky M, Martinikova M, Nosal V, Kantorova E, Ballova J, et al.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
. 2021 May;
166(1):84-90.
PMID: 33976431
Introduction: Loss of consciousness (LOC) is used as a diagnostic feature of mild traumatic brain injury (MTBI). However, only 10% of concussions result in LOC. There are only a limited...
17.
Kantorova E, Vajdova V, Hnilicova P, Tarcak M, Turcanova M, Kurca E, et al.
Ther Adv Neurol Disord
. 2020 Sep;
13:1756286420954081.
PMID: 32973926
Alemtuzumab, one of the very effective immunomodulatory forms of treatment for patients with highly active multiple sclerosis, can also have unexpected side effects. We present a case of cystic echinococcosis...
18.
Hnilicova P, Strbak O, Kolisek M, Kurca E, Zelenak K, Sivak S, et al.
Int J Mol Sci
. 2020 Aug;
21(17).
PMID: 32854318
Multiple sclerosis (MS) is an autoimmune disease with expanding axonal and neuronal degeneration in the central nervous system leading to motoric dysfunctions, psychical disability, and cognitive impairment during MS progression....
19.
Hnilicova P, Kantorova E, Polacek H, Grendar M, Bittsansky M, cierny D, et al.
J Neurol Sci
. 2019 Oct;
407:116458.
PMID: 31622679
Multiple sclerosis (MS) is a disease characterized by overlapping processes of neuroinflammation and neuro-axonal degeneration. Disturbances of the hypothalamo-pituitary axis in MS are supposed to modulate neuroinflammatory circuits, however, there...
20.
Polacek H, Kantorova E, Hnilicova P, Grendar M, Zelenak K, Kurca E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
. 2018 Aug;
163(1):45-53.
PMID: 30150790
Objective: In multiple sclerosis (MS), deep grey matter (DGM) atrophy has been recognised as a crucial component of the disease that presents early and it has been associated with disability....